Abstract:Aberrations of MAM integrity are considered as a cornerstone in the pathogenesis of several inflammation‐mediated metabolic diseases neurodegenerative diseases, CVD, and cancer. Mitochondria‐associated endoplasmic reticulum membranes (MAM) are specialized subcellular compartments that are shaped by endoplasmic reticulum (ER) subdomains placed side by side to the outer membrane of mitochondria (OMM) being connected by tethering proteins in mammalian cells. Studies showed that MAM has multiple physiological functions. These include regulation of lipid synthesis and transport, Ca2+ transport and signaling, mitochondrial dynamics, apoptosis, autophagy, and formation and activation of an inflammasome. However, alterations of MAM integrity lead to deleterious effects due to an increased generation of mitochondrial reactive oxygen species (ROS) via increased Ca2+ transfer from the ER to mitochondria. This, in turn, causes mitochondrial damage and release of mitochondrial components into the cytosol as damage‐associated molecular patterns which rapidly activate MAM‐resident Nod‐like receptor protein‐3 (NLRP3) inflammasome components. This complex induces the release of pro‐inflammatory cytokines that initiate low‐grade chronic inflammation that subsequently causes the development of metabolic diseases. But, the mechanisms of how MAM is involved in the pathogenesis of these diseases are not exhaustively reviewed. Therefore, this review was aimed to highlight the contribution of MAM to a variety of cellular functions and consider its significance pertaining to the pathogenesis of inflammation‐mediated metabolic diseases.

Mitochondrial Contact Sites in Inflammation-Induced Cardiovascular Disease

Mitochondria-associated membrane-modulated Ca<SUP>2+</SUP> transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

Unraveling the complex interplay between Mitochondria-Associated Membranes (MAMs) and cardiovascular Inflammation: Molecular mechanisms and therapeutic implications

Mitochondria-Associated Endoplasmic Reticulum Membranes in Cardiovascular Diseases

Structure and Function of Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs) and Their Role in Cardiovascular Diseases

Mitochondria-associated endoplasmic reticulum membranes as a therapeutic target for cardiovascular diseases

So close, yet so far away: the relationship between MAM and cardiac disease

Role of Mitochondria-Associated Endoplasmic Reticulum Membrane in Inflammation-Mediated Metabolic Diseases

The mitochondrial associated endoplasmic reticulum membranes: A platform for the pathogenesis of inflammation‐mediated metabolic diseases

Cell death regulation by MAMs: from molecular mechanisms to therapeutic implications in cardiovascular diseases

The role of mitochondria-associated membranes mediated ROS on NLRP3 inflammasome in cardiovascular diseases

Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging.

Mitochondrial Control of Innate Immune Responses

Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease

Mitochondria-Endoplasmic Reticulum Contacts: The Promising Regulators in Diabetic Cardiomyopathy

Assessment of mitochondrial dysfunction and implications in cardiovascular disorders

Dialogue between mitochondria and endoplasmic reticulum-potential therapeutic targets for age-related cardiovascular diseases

The Emerging Role of FUNDC1-Mediated Mitophagy in Cardiovascular Diseases

Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality

Current insights on mitochondria-associated endoplasmic reticulum membranes (MAMs) and their significance in the pathophysiology of ocular disorders

Compositions and Functions of Mitochondria-Associated Endoplasmic Reticulum Membranes and Their Contribution to Cardioprotection by Exercise Preconditioning